Clinical Trial Update: A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating elamipretide topical ophthalmic solution for safety, tolerability, and efficacy in Fuchs' Corneal Endothelial Dystrophy has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fuchs Corneal Endothelial Dystrophy

Drugs mentioned

• elamipretide topical ophthalmic solution (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Fuchs' Corneal Endothelial Dystrophy (FCED) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-09-17